Barchart Research What to Expect from PHVS Earnings PHVS Generated May 11, 2026 Current Price $30.00 EPS Estimate $$-0.76 Consensus Rating Strong Buy Average Move 4.91% Pharvaris Reports Earnings Days...
Monday U.S. Featured Earnings Pharvaris NV (NASDAQ: PHVS) (Q4) EPS for loss of 69 cents, ...
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up by +0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.20%. December...
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.06%. December E-mini S&P...
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.49%. December E-mini S&P...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abbott Laboratories (ABT – Research Report), Amgen (AMGN – Research Report) and Pharvaris (PHVS – Research Report).Elevate...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG – Research Report), Pharvaris (PHVS – Research Report) and Stevanato Group (STVN –...
In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Pharvaris, with a price target of $34.00. The company’s shares closed last Friday at $23.39.Elevate Your Investing...
Monday U.S. Featured Earnings Legend Biotech Corporation (NASDAQ: LEGN) (Q1) EPS ...
Monday U.S.Economic Lookahead S&P U.S. manufacturing PMI (final) (Mar.) Construction ...